Calliditas Therapeutics: Q3 Earnings Insights

Calliditas Therapeutics CALT reported its Q3 earnings results on Thursday, November 18, 2021 at 01:00 AM.

Here's what investors need to know about the announcement.

Calliditas Therapeutics their estimated earnings by 103.51%, reporting an EPS of $0.02 versus an estimate of $-0.57, which surprised analysts.

Revenue was up $22,928,000.00 from the same period last year.

Last quarter the company missed on EPS by $0.28, which was followed by a 4.02% drop in the share price the next day.

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.